CVE-2026-19731 Details
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in TÜBİTAK BİLGEM Software Technologies Research Institute İmzager allows Path Traversal. This issue affects İmzager: from 2.10.5 before 2.10.7.
A path traversal vulnerability has been identified in TÜBİTAK BİLGEM Software Technologies Research Institute's İmzager product, specifically in versions 2.10.5 prior to 2.10.7. This vulnerability allows for improper limitation of a pathname to a restricted directory, enabling attackers to traverse directories and potentially access unauthorized files.
Users are advised to upgrade to version 2.10.7 or later.
Metrics
CVSS 4.0 Severity and Vector Strings:
VolerionCVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
Volerion
Assessed Nov 4, 2026References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://siberguvenlik.gov.tr/guvenlik-bildirimleri/detay/tr-26-1456 | [email protected] | AdvisoryBundleRemedy |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-22 | Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| TÜBİTAK BİLGEM İmzager | >= 2.10.5, < 2.10.7 (semver) |
CPE
Remediation
| |
Change History
1 change record found show changes
| Date | Action | Recorded By |
|---|---|---|
| Nov 4, 2026 | New CVE Received | [email protected] |